Cafepharma Today

January 14 2025 - 5 questions facing emerging biotech in 2025
5 questions facing emerging biotech in 2025
Healthcare dealmakers eye M&A resurgence in second Trump term
Reduced dosing and expanded manufacturing paving way for Amgen’s obesity entrance
Merck is broadening its pipeline as Keytruda’s patent cliff looms
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

Amgen, Takeda's Drug for Lung Cancer Suspended After Deaths
Bloomberg
Thursday, November 20, 2008 - 7:36am
tags:
Novartis: New research strategies paying off
Yahoo/AP
Wednesday, November 19, 2008 - 10:46am
tags:
Amid Big Pharma Woes, Shire in “Best Shape Ever”
PharmExec
Wednesday, November 19, 2008 - 10:22am
tags:
FDA 'black box' warning advised for cancer drug Avastin
USA Today
Wednesday, November 19, 2008 - 10:14am
tags:
Novo Nordisk: Approval of New Diabetes Drug Is Further Postponed
Seeking Alpha
Wednesday, November 19, 2008 - 10:12am
tags:
Teva gets FDA approval for generic asthma drug
Yahoo/AP
Wednesday, November 19, 2008 - 10:06am
tags:
FTC To Hold Roundtable On Follow-On Biologics
Pharmalot
Wednesday, November 19, 2008 - 10:03am
tags:
AstraZeneca: FDA Agrees with Some Pulmicort Concerns
Easy Bourse, France
Wednesday, November 19, 2008 - 10:02am
tags:
Elan seeks deals to raise cash
Reuters
Wednesday, November 19, 2008 - 10:00am
tags:
A Heavy Heart: The FDA Weighs CV Side Effects
Pharmalot
Wednesday, November 19, 2008 - 9:58am
tags:
More Pressure to Curb Antipsychotic Use in Kids
WSJ Online
Wednesday, November 19, 2008 - 9:51am
tags:
Big Pharma Steps Up China Investment
Seeking Alpha
Wednesday, November 19, 2008 - 9:51am
tags:
Glaxo rejected Maryland doctor's Avandia warning: report
Marketwatch
Wednesday, November 19, 2008 - 9:49am
tags:
Sanofi Settles Allergy Drugs Dispute With Barr, Teva
Bloomberg
Wednesday, November 19, 2008 - 9:48am
tags:
Novartis to Combine Heart Pills as Afinitor Cancer Drug Delayed
Bloomberg
Wednesday, November 19, 2008 - 9:46am
tags:
Are Costly Diabetes Pills Doing Any Good?
Pharmalot
Wednesday, November 19, 2008 - 2:02am
tags:
Pfizer And Wyeth Sued By Nevada Attorney General
Pharmalot
Wednesday, November 19, 2008 - 1:57am
tags:
Eli Lilly sues 4 generic drugmakers to protect the patent guarding lucrative Cymbalta
Yahoo/AP
Wednesday, November 19, 2008 - 1:52am
tags:
FDA panel to assess new use for J&J catheter
Yahoo/AP
Wednesday, November 19, 2008 - 1:52am
tags:
NitroMed and Archemix Announce Merger Agreement
Yahoo
Wednesday, November 19, 2008 - 1:49am
tags:

Pages

Latest CP Wire Articles

FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business

Latest Pharmagather Articles

Why 340B Reform Could Happen in 2025 (video)
Drug Channels
Drug Channels Leadership Forum: Request an Invitation Before It’s Too Late!
Drug Channels
The Pain Comes With the Territory
In the Pipeline
A New Antiviral Target, On the Host Side
In the Pipeline
Inside a Fentanyl Kitchen
In the Pipeline
Inflation-Adjusted U.S. Brand-Name Drug Prices Fell for the Seventh Consecutive Year as a New Era of Drug Pricing Dawns
Drug Channels
Carbyne Remains Elusive
In the Pipeline
Another GLP-1 Year
In the Pipeline
Two More Great Names Pass
In the Pipeline

Latest Jobs

Account Executive
McAlester, Oklahoma, 74502
Elara Caring
Account Executive
San Antonio, Texas, 78284
Elara Caring
Account Executive
Wichita Falls, Texas, 76309
Elara Caring
Account Executive
Dallas, Texas, 75219
Elara Caring
Account Executive, Home Health
Austin, Texas, 78703
AccentCare, Inc.
Account Executive
Monroe, Louisiana, 71201
Elara Caring
Account Executive
Clinton Township, Michigan, 48036
Elara Caring
Sales Representative- Wilmington/Harrisburg- Communications
Lancaster, Pennsylvania, 17699
Stryker
Sales Representative- Southern MD- Communications
Washington, District of Columbia, 20080
Stryker
Account Executive, Home Health
Temple, Texas, 76504
AccentCare, Inc.
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information